Effect of infectious diseases on outcome after heart transplant

Mayo Clinic Proceedings

Volumn 83, Issue 3, 2008, Pages 304-308

  Van De Beek, Diederik ^a   Kremers, Walter K ^a   Del Pozo, Jose L ^a   Daly, Richard C ^a   Edwards, Brooks S ^a   McGregor, Christopher G A ^a   Patel, Robin ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CREATININE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM INFECTION; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DRUG SUBSTITUTION; FEMALE; HEART GRAFT; HUMAN; INCIDENCE; INFECTION; KIDNEY FUNCTION; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; RECIPIENT; RETROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; SKIN INFECTION; SOFT TISSUE INFECTION; SURGICAL MORTALITY; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

EID: 41549105004     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/83.3.304     Document Type: Article

References (17)

1. Scientific Registry of Transplant Recipients. http://www.ustransplant. org. Accessed January 23, 2008.
2. Jennet B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1(7905):480-484.
3. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18(6):695-706.
4. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: Wiley; 2002.
5. van de Beek D, Patel R, Daly RC, McGregor CG, Wijdicks EF. Central nervous system infections in heart transplant recipients. Arch Neurol. 2007 Dec;64(12):1715-1720. Epub 2007 Oct 8.
6. Cisneros JM, Munoz P, Torre-Cisneros J, et al, Spanish Transplantation Infection Study Group. Pneumonia after heart transplantation: a multi-institutional study. Clin Infect Dis. 1998;27(2):324-331.
7. Atasever A, Bacakoglu F, Uysal FE, et al. Pulmonary complications in heart transplant recipients. Transplant Proc. 2006;38(5):1530-1534.
8. Augustine JJ, Bodziak KA, Hricik DE. Use of sirolimus in solid organ transplantation. Drugs. 2007;67(3):369-391.
9. Eisen HJ, Tuzcu EM, Dorent R, et al, RAD B253 Study Group. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med. 2003;349(9):847-858.
10. Kahan BD, Rapamune US Study Group. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. Lancet. 2000;356(9225):194-202.
11. Snell GI, Levvey BJ, Zheng L, et al. Everolimus alters the bronchoalveolar lavage and endobronchial biopsy immunologic profile post-human lung transplantation. Am J Transplant. 2005;5(6):1446-1451.
12. Champion L, Stern M, Israël-Biet D, et al. Brief communication: sirolimus-associated pneumonitis: 24 cases in renal transplant recipients. Ann Intern Med. 2006;144(7):505-509.
13. Heininger U, Seward JF. Varicella (published correction appears in Lancet. 2007;369(9561):558). Lancet. 2006;368(9544):1365-1376.
14. Gourishankar S, McDermid JC, Jhangri GS, Preiksaitis JK. Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant. 2004;4(1):108-115.
15. Arness T, Pedersen R, Dierkhising R, Kremers W, Patel R. Varicella zoster virus-associated disease in adult kidney transplant recipients: incidence and risk factor analysis. Transpl Infect Dis. 2007 Dec 11 [Epub ahead of print].
16. Cainelli F, Vento S. Infections and solid organ transplant rejection: a cause-and-effect relationship (published correction appears in Lancet Infect Dis. 2002;2(10):645)? Lancet Infect Dis. 2002;2(9):539-549.
17. Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007;44(suppl 1):S1-S26.